Banca di Materiale Biologico Per lo Studio di Patologie Che Interessano l'Apparato Muscolo-scheletrico
Launched by I.R.C.C.S OSPEDALE GALEAZZI-SANT'AMBROGIO · Jun 30, 2017
Trial Information
Current as of September 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on creating a biobank, which is a collection of human biological samples, to help researchers study musculoskeletal disorders. These disorders, which affect our muscles and bones, are a leading cause of disability. By gathering samples from patients with conditions like osteoarthritis or bone tumors, the researchers hope to gain deeper insights that could lead to better treatments and understanding of these diseases.
To participate in this trial, individuals must be at least 18 years old and currently receiving treatment at the institute. Eligible patients include those with osteoarthritis of the hip or knee, certain types of bone tumors, or those undergoing surgery for infections related to implants. Participants will be asked to provide biological samples, and their contributions will support important research. If you or a loved one fits the criteria and are interested in helping advance medical knowledge, this trial could be a valuable opportunity.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients admitted to our Institute
- • Patients aged ≥18 years
- • Patients with osteoarthritis of hip or knee and rehabilitated in the institute
- • Patients with primary and secondary tumors of the skeleton
- • Patients undergoing prosthetic surgery following infection of the implant
- Exclusion Criteria:
- • Participants aged \<18 years
- • Participants unable to release the Informed Consent
About I.R.C.C.S Ospedale Galeazzi Sant'ambrogio
The I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio is a leading clinical research institute and hospital in Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As a designated Institute of Hospitalization and Care of Scientific Relevance (I.R.C.C.S.), it focuses on translational research that bridges the gap between laboratory findings and clinical applications. The facility is equipped with state-of-the-art technology and a multidisciplinary team of experts, enabling it to conduct a wide range of clinical trials aimed at improving treatment outcomes across various medical fields. Its dedication to ethical practices and patient safety ensures that all research activities align with the highest international standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, Italy
Milano, Italy
Milan, Italy
Patients applied
Trial Officials
Giuseppe Banfi
Principal Investigator
IRCCS Istituto Ortopedico Galeazzi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials